The sequencing effort produced a single circular chromosome of 3,929,792 base pairs with a GC content of 46.5 percent, a size and composition typical of members of the Bacillus subtilis species group but notable for its completeness and quality. Annotation of the genome identified 3,781 protein-coding genes, alongside 27 ribosomal RNA genes, 86 transfer RNA genes and 5 non-coding RNA genes, indicating a highly functional translational apparatus consistent with a fast-growing, metabolically versatile organism. Beyond the core gene complement, the researchers detected four genomic islands, four prophages and four CRISPR sequences, features that speak to a dynamic evolutionary history shaped by horizontal gene transfer and viral assault. Prophages can carry genes that influence host physiology and competitiveness, while CRISPR arrays record past encounters with invading genetic elements, together providing a fingerprint of the ecological pressures this bacterium has survived within its plant host.

The most striking discovery, however, lies in the bacterium’s chemical arsenal. ML21’s genome harbors no fewer than twelve secondary metabolite gene clusters, the genetic blueprints for complex molecules that microbes use to compete, defend and communicate. Seven of these clusters show high similarity, either 100 percent or 82 percent, to known clusters responsible for synthesizing some of the most celebrated antimicrobial compounds in the Bacillus repertoire: the nonribosomal lipopeptides surfactin, fengycin and bacilysin, and the polyketides difficidin, macrolactin H and bacillaene. Each of these molecules has an established reputation in the biocontrol literature. Surfactin is a powerful biosurfactant that disrupts bacterial membranes and can induce systemic resistance in plants. Fengycin attacks fungal cell membranes and is considered one of the most potent antifungal lipopeptides produced by Bacillus species. Bacilysin, a simple dipeptide antibiotic, interferes with protein synthesis in competing bacteria. Difficidin and macrolactin are broad-spectrum polyketide antibiotics, while bacillaene inhibits protein synthesis in prokaryotes, quietly suppressing microbial rivals before they can establish infection.

The fact that these clusters are present together in a single genome explains much of ML21’s observed potency in laboratory antagonism assays. Rather than relying on one mechanism, the strain deploys a layered defense: lipopeptides that puncture membranes, polyketides that sabotage protein production, and siderophores that starve competitors of iron. Two siderophore clusters, those for bacillibactin and butirosin A/B, were also identified, although they showed much lower similarity to reference sequences, at only 7 percent, hinting at possible structural variation worth further biochemical investigation. Siderophores are small molecules that chelate iron in the environment, and by sequestering this essential nutrient, biocontrol bacteria can deprive pathogens of a resource they need to grow and cause disease.

Perhaps the most tantalizing aspect of the study is the identification of four completely novel secondary metabolite clusters, predicted to encode two terpenes, one lanthipeptide and one polyketide. Terpenes are a vast and chemically diverse class of natural products, many of which possess antimicrobial or signaling properties. Lanthipeptides are members of the ribosomally synthesized and post-translationally modified peptide family, whose members often exhibit potent antibacterial activity through novel mechanisms. The existence of uncharted biosynthetic machinery in ML21 raises the possibility of entirely new antimicrobial compounds waiting to be isolated and characterized, a prospect that will interest natural product chemists as much as agricultural scientists. In an era when antibiotic discovery has slowed to a trickle and resistance genes are spreading across pathogens of both plants and humans, the genomes of environmental and endophytic bacteria have become one of the most promising hunting grounds for new chemistry.

ML21 is not only a fighter; it is also a gardener. The genome contains genes implicated in promoting plant growth, including trpC, which participates in the biosynthesis of indole-3-acetic acid, the principal auxin hormone that stimulates root development and overall plant vigor, and acoA, involved in producing acetoin, a volatile organic compound known to elicit induced systemic resistance in plants. Acetoin emitted by rhizobacteria has been shown to prime plant immune defenses, effectively vaccinating the host against subsequent pathogen attack. The presence of both direct growth promotion genes and defense-triggering pathways suggests that ML21 may benefit its host through multiple simultaneous routes: improving nutrient uptake and hormonal balance while actively suppressing disease organisms and stimulating the plant’s own immune responses.

The ecological context of ML21 adds further weight to these findings. As an endophyte isolated from mango fruit, the bacterium lives inside plant tissue, a privileged niche where it can interact closely with its host and with pathogens attempting the same invasion. Mango cultivation suffers from serious bacterial and fungal diseases, including bacterial black spot caused by Xanthomonas citri pv. mangiferaeindicae, a pathogen whose genome has been sequenced in recent years, as well as postharvest rots that cause substantial losses between orchard and market. The authors’ earlier work had shown that ML21 inhibits a variety of rice pathogens as well, suggesting a broad host-relevant activity that could extend beyond a single crop. The new genome sequence now provides the mechanistic explanation: a dense concentration of antimicrobial biosynthetic clusters that few competing pathogens could easily withstand simultaneously.

The broader significance of the study lies in the mounting scientific and commercial interest in Bacillus velezensis as a biocontrol agent. The species has emerged over the past decade as one of the most promising candidates for replacing or reducing synthetic pesticides and chemical fertilizers in sustainable agriculture. Its spore-forming ability allows formulation into stable products with long shelf life, its lipopeptides degrade readily in the environment, and its plant growth-promoting traits offer yield benefits alongside disease suppression. By providing the complete genome of a fruit-derived endophytic strain, the Guangxi team has added a valuable reference resource for comparative genomics, enabling researchers to pinpoint the genetic differences that determine why some strains are exceptional antagonists while close relatives are not. The genome has been deposited in GenBank under accession number NZ_CP150636, making it freely available to the research community.

Looking ahead, the genomic blueprint of ML21 opens several concrete avenues. The four novel biosynthetic clusters invite heterologous expression or fermentation studies to determine what compounds they actually produce and whether those molecules are active against pathogens. The complete set of lipopeptide and polyketide genes supports targeted strain improvement through metabolic engineering, potentially boosting yields of the most effective antimicrobials. And the combination of biocontrol and plant growth-promoting genes strengthens the case for field trials in mango orchards and rice paddies, where the strain’s dual talents could translate into reduced chemical inputs and healthier harvests. In a small chromosome of fewer than four million base pairs, this mango-dwelling microbe has packed an encyclopedia of defensive chemistry, and scientists are only beginning to read it.

Subject of Research: Complete genome sequencing of the biocontrol endophytic bacterium Bacillus velezensis ML21 isolated from mango fruit

Article Title: Complete genome sequencing of Bacillus velezensis ML21, an endophytic strain from mango fruit with strong inhibitory against bacterial and fungal diseases

Article References: Complete genome sequencing of Bacillus velezensis ML21, an endophytic strain from mango fruit with strong inhibitory against bacterial and fungal diseases. (n.d.). https://doi.org/10.1007/s13205-026-04994-7

Image Credits: AI Generated

DOI: 10.1007/s13205-026-04994-7

Keywords: Bacillus velezensis, whole-genome sequencing, secondary metabolite gene clusters, biocontrol, endophytic bacteria, mango, lipopeptides, surfactin, fengycin, plant growth promotion, sustainable agriculture, plant pathogens

Researchers led by Nadarajan Viju of AMET University in Chennai, together with colleagues at Smykon Biotech and King Abdulaziz University, took a genomics-first approach to antifouling discovery. Rather than screening crude bacterial extracts, they mined the whole genomes of 30 marine bacteria belonging to the genera Pseudovibrio, Pseudomonas and Bacillus, all retrieved from the NCBI GenBank database. Using the open-source gene mining platform AntiSMASH, they mapped the biosynthetic gene clusters, or BGCs, the sets of genes that encode the enzymatic machinery for producing secondary metabolites. Each genome carried between 5 and 17 such clusters, yielding 278 clusters in total across the 30 organisms analysed.

The clusters fell into familiar categories: non-ribosomal peptide synthetases accounted for 28 percent, ribosomally synthesized and post-translationally modified peptides for 15 percent, terpenes for 11 percent, polyketide synthases for 9 percent, NRPS-PKS hybrids for 5 percent, siderophores for 6 percent, and a mixed bag of other clusters for the remaining 26 percent. Every species produced its own characteristic repertoire, with Pseudovibrio strains predicted to make compounds such as pyoverdin, rimosamide, prodigiosin and pseudaminic acid, Pseudomonas strains predicted to yield viscosin, pyoluteorin, mitomycin and ectoine among others, and Bacillus strains carrying genes for surfactin, bacillaene, difficidin, bacilysin and lichenysin, to name only a few.

But one compound stood out for its ubiquity. Fengycin, a cyclic lipopeptide encoded by a 22,502-base-pair non-ribosomal peptide synthetase cluster, was predicted in 26 of the 30 genomes, or 86.66 percent of all strains analysed. It was present in every one of the ten Pseudovibrio genomes, in 90 percent of the Pseudomonas genomes and in 70 percent of the Bacillus genomes. The authors argue that this broad distribution suggests fengycin acts as a conserved ecological trait, a chemical weapon that helps its producers compete for space and nutrients, colonize surfaces and survive in densely populated marine biofilms. In other words, the compound may represent a chemical defence strategy honed by evolution in exactly the kind of surface-bound microbial communities that kick off biofouling.

To test whether fengycin could plausibly block fouling at the molecular level, the team turned to structure-based virtual screening. They docked fengycin, obtained from the PubChem database, against six target proteins retrieved from the Protein Data Bank: the penicillin-binding protein of Acinetobacter baumannii and the lanosterol 14-alpha demethylase of Candida albicans as antimicrobial targets; a bacterial cell surface protein and the acyl-homoserine lactone synthase LasI, a quorum-sensing enzyme, as antibiofilm targets; and the barnacle cement protein and the mussel proximal thread matrix protein, which mediate larval adhesion, as antifouling targets. The docking was performed in PyRx using AutoDock Vina with an exhaustiveness value of eight, generating nine binding poses per ligand, with penicillin G, fluconazole and the commercial biocide DCOIT serving as reference ligands.

The results were striking. Fengycin achieved predicted binding affinities well ahead of every reference compound at every target. Against the penicillin-binding protein it scored minus 11.4 kilocalories per mole, compared with minus 6.7 for DCOIT. Against the fungal lanosterol demethylase it reached minus 13.3 kilocalories per mole, far beyond fluconazole’s minus 5.2. Its scores against the bacterial cell surface protein, the AHL synthase LasI, the barnacle cement protein and the mussel byssus protein were minus 15.3, minus 14.0, minus 14.2 and minus 13.1 kilocalories per mole respectively, while DCOIT managed only minus 7.3, minus 6.1, minus 5.5 and minus 5.61. Triplicate docking runs showed standard deviations below 0.5 kilocalories per mole, and redocking validation returned root-mean-square deviation values below the accepted threshold of 2.0 angstroms, confirming that the protocol reliably reproduced known binding orientations.

Visualization of the ligand-receptor complexes in PyMOL and BIOVIA Discovery Studio Visualizer explained the affinity. Fengycin formed extensive networks of polar and non-polar contacts: hydrogen bonds with residues such as GLU67 and LYS137 in the penicillin-binding protein, ARG381 in the fungal demethylase, SER374, SER520 and THR662 in the cell surface protein, HIS399 in LasI, GLN165 and GLU192 in the barnacle cement protein, and multiple residues in the mussel thread matrix protein, alongside dense hydrophobic contacts throughout each pocket. The researchers attribute this versatility to fengycin’s amphiphilic architecture, a rigid cyclic peptide ring fused to a hydrophobic beta-hydroxy fatty acid chain. The ring supplies multiple hydrogen bond donors and acceptors while limiting entropic penalties on binding, and the lipid tail drives van der Waals interactions within non-polar regions, allowing the molecule to engage diverse targets simultaneously.

The computational findings dovetail with decades of experimental literature on fengycin’s bioactivity. Studies have documented its antifungal action against Fusarium moniliforme, Botrytis cinerea and Magnaporthe grisea, its antibacterial effects against Xanthomonas and Pseudomonas pathogens, and, notably, its ability to disrupt quorum sensing in Staphylococcus aureus, a result reported in Nature in 2018 that aligns closely with the strong predicted interaction between fengycin and the quorum-sensing enzyme LasI in the present study. Because biofilms serve as settlement cues for many macrofoulers, a compound that interferes with both microbial adhesion and quorum sensing could in principle suppress fouling at multiple stages, from initial colonization through larval recruitment, in contrast to traditional biocides that simply poison organisms indiscriminately.

The authors are careful to frame the work as hypothesis-generating rather than conclusive. Molecular docking offers a static, simplified picture of binding that ignores protein flexibility, solvent effects, bioavailability, toxicity and cellular context, and docking scores are sensitive to ligand size, so fengycin’s large surface area may inflate its apparent advantage over small molecules like DCOIT. BGC predictions similarly depend on genome assembly quality and database annotations, and the predicted metabolites remain putative until chemically verified. The comparison with DCOIT, a biocide with documented environmental concerns of its own, must likewise be treated with caution given the compounds’ very different molecular dimensions and physicochemical properties.

Even so, the study sketches a compelling vision for the future of antifouling technology. Fengycin is biodegradable, reportedly low in toxicity, stable across ranges of temperature, pH and salinity, and potentially effective at low concentrations, making it an attractive starting point for eco-friendly coatings. More broadly, the work demonstrates that coupling genome mining with molecular docking can rapidly link biosynthetic potential to plausible biological function, providing a genomics-guided framework for prioritizing marine natural products before any laboratory assay is run. The next step is clear: in vitro and in vivo validation against real fouling organisms, together with toxicity testing, will determine whether this bacterial chemical weapon can be translated into the antifouling paints of a post-TBT world.

The study’s genome-guided strategy reflects a broader shift in natural products research. Traditional antifouling discovery relied on collecting marine organisms, extracting compounds and testing them laboriously in assays, a process that is slow, expensive and often non-specific. By contrast, mining publicly available genomes with tools like AntiSMASH allows researchers to survey the biosynthetic potential of dozens of organisms computationally before committing laboratory resources, prioritizing the most promising candidates for synthesis and testing.

Fengycin itself is well characterized biochemically. It belongs to a family of lipopeptides produced by Bacillus species alongside surfactin and iturin, and its cyclic peptide ring is assembled by large non-ribosomal peptide synthetase enzymes rather than by ribosomes, which permits the incorporation of unusual amino acids and contributes to its structural diversity. Its amphiphilic nature, combining a polar peptide head with a fatty acid tail, underlies both its surface activity and its ability to interact with biological membranes, properties that have made lipopeptides of interest as biocontrol agents in agriculture as well as in marine applications.

The choice of target proteins in the docking analysis also illustrates how antifouling can be attacked at distinct biological stages. Blocking quorum-sensing enzymes such as LasI could prevent bacteria from coordinating biofilm formation, while disrupting adhesion proteins used by barnacle larvae and mussels could stop macrofoulers from settling on a surface already colonized by microbes. A single compound active against both microbial and invertebrate targets would therefore offer multi-stage protection, a property conventional biocides achieve only through broad toxicity. The authors emphasize, however, that docking predictions must now be followed by laboratory and field validation before any practical coating can emerge.

Subject of Research: In silico prediction of the antifouling potential of the marine bacterial cyclic lipopeptide fengycin

Article Title: An in silico antifouling potential of fengycin, a cyclic lipopeptide produced by marine bacteria

Article References: Viju, N., Vijayaraghavan, P., Satheesh, S., & Jayaprakashvel, M. (2026). An in silico antifouling potential of fengycin, a cyclic lipopeptide produced by marine bacteria. Discover Oceans, 3(1), Article 51. https://doi.org/10.1007/s44289-026-00164-y

Image Credits: AI Generated

DOI: 10.1007/s44289-026-00164-y

Keywords: marine bacteria, fengycin, cyclic lipopeptide, biosynthetic gene clusters, antifouling, antibiofilm, molecular docking, AntiSMASH, biofouling, quorum sensing, natural products, silico